You have 9 free searches left this month | for more free features.

City

Wuhan (3)

Condition

Leber Hereditary Optic Neuropathy (2)

Acute LHON (1)

Onset Between 12 to 24 Months (1)

Onset Between 24 to 60 Months (1)

Onset Between 3 to 6 Months (1)

Onset Between 6 to 12 Months (1)

Onset Over 60 Months (1)

Onset Within Three Months (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Unknown status (1)

Sign in for free

Phase

n/a (2)

phase 2/phase 3 (1)

Sponsor

Bin Li (2)

Huazhong University of Science and Technology (1)

Collaborator

Huazhong University of Science and Technology (1)

Shiyan Taihe Hospital (1)

Intervention

raav2-nd4 (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (3)

raav2-nd4

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)

Active, not recruiting

Leber Hereditary Optic Neuropathy

rAAV2-ND4

Wuhan, Hubei, China

Department of Ophthalmology，Tongji Hospital, Tongji Medical Coll

Sep 15, 2020

Acute LHON, Onset Within Three Months, Onset Between 3 to 6 Months Trial in Wuhan (rAAV2-ND4)

Unknown status

Acute LHON
+6 more

rAAV2-ND4

Wuhan, Hubei, China

Department of Ophthalmology ，Tongji Hospital, Tongji Medical Col

Jul 27, 2020

Leber Hereditary Optic Neuropathy Trial in Wuhan (rAAV2-ND4)

Completed

Has Results

Leber Hereditary Optic Neuropathy

rAAV2-ND4

Wuhan, Hubei, China

Department of Ophthalmology ，Tongji Hospital, Tongji Medical Col

Jan 7, 2018